SILVERBACK THERAPEUTICS

silverback-therapeutics-logo

Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways. They developing a new generation of systemically delivered, locally active therapies that potently modulate fundamental disease pathways once deemed inaccessible. Silverback Therapeutics is building a platform technology capable of unlocking potent immuno-modulatory pathways using an established antibody-guided approach for targeting disease sites. The company's proprietary ImmunoTAC technology and integrated R&D approach enables the design of product candidates that can be administered systemically, but that act only at the sites of disease.

#SimilarOrganizations #People #Financial #Website #More

SILVERBACK THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Health Care Medical Therapeutics

Founded:
2016-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.silverbacktx.com

Total Employee:
11+

Status:
Active

Contact:
(206) 456-2900

Email Addresses:
[email protected]

Total Funding:
221 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Wordpress Plugins


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

harmony-biosciences-logo

Harmony Biosciences

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

interius-biotherapeutics-logo

Interius BioTherapeutics

Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.

kinnate-biopharma-logo

Kinnate Biopharma

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.

projenx-logo

ProJenX

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

vivace-therapeutics-logo

Vivace Therapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.


Current Advisors List

jonathan-root_image

Jonathan Root Board Member @ Silverback Therapeutics
Board_member

thilo-schroeder_image

Thilo Schroeder Board Member @ Silverback Therapeutics
Board_member

Current Employees Featured

peter-thompson_image

Peter Thompson
Peter Thompson Co-Founder, Chairman, CEO @ Silverback Therapeutics
Co-Founder, Chairman, CEO
2016-04-01

valerie-odegard_image

Valerie Odegard
Valerie Odegard Chief Scientific Officer @ Silverback Therapeutics
Chief Scientific Officer
2016-10-01

jeffrey-pepe_image

Jeffrey Pepe
Jeffrey Pepe SVP, General Counsel @ Silverback Therapeutics
SVP, General Counsel
2019-08-01

laura-shawver_image

Laura Shawver
Laura Shawver President and CEO @ Silverback Therapeutics
President and CEO
2020-04-01

patricia-leith_image

Patricia Leith
Patricia Leith Vice President of Program Management and Operations @ Silverback Therapeutics
Vice President of Program Management and Operations
2018-12-01

not_available_image

Sathish Nagarajan
Sathish Nagarajan Vice President, Product Development @ Silverback Therapeutics
Vice President, Product Development
2019-01-01

sue-hamke_image

Sue Hamke
Sue Hamke Vice President, Clinical Operations @ Silverback Therapeutics
Vice President, Clinical Operations
2019-01-01

naomi-hunder_image

Naomi Hunder
Naomi Hunder Senior Vice President of Clinical Research and Development @ Silverback Therapeutics
Senior Vice President of Clinical Research and Development
2019-01-01

jill-herendeen_image

Jill Herendeen
Jill Herendeen VP, Regulatory Affairs @ Silverback Therapeutics
VP, Regulatory Affairs
2019-02-01

not_available_image

Peter Baum
Peter Baum VP of Immunology @ Silverback Therapeutics
VP of Immunology
2016-06-01

Founder


badreddin-edris_image

Badreddin Edris

peter-thompson_image

Peter Thompson

Stock Details


Company's stock symbol is NASDAQ:SBTX

Investors List

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series C - Silverback Therapeutics

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series C - Silverback Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Silverback Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Silverback Therapeutics

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series C - Silverback Therapeutics

pontifax_image

Pontifax

Pontifax investment in Series C - Silverback Therapeutics

hunt-technology-ventures_image

Hunt Technology Ventures

Hunt Technology Ventures investment in Series C - Silverback Therapeutics

boxer-capital_image

Boxer Capital

Boxer Capital investment in Series C - Silverback Therapeutics

us-venture-partners_image

U.S. Venture Partners

U.S. Venture Partners investment in Series C - Silverback Therapeutics

nantahala-capital-management_image

Nantahala Capital Management

Nantahala Capital Management investment in Series C - Silverback Therapeutics

Official Site Inspections

http://www.silverbacktx.com Semrush global rank: 3.3 M Semrush visits lastest month: 4.92 K

  • Host name: 104.21.25.158
  • IP address: 104.21.25.158
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Silverback Therapeutics" on Search Engine